The T cell immunosenescence profile of patients with newly diagnosed multiple myeloma as an indicator of frailty: Preliminary data from the immuno-NDMM protocol.
Sign Up to like & getrecommendations! Published in 2025 at "Blood"
DOI: 10.1182/blood-2025-5786
Abstract: BACKGROUND Fit and young (< 65 years) patients (pts) with newly diagnosed Multiple Myeloma (NDMM) are candidates to high dose chemotherapy followed by autologous stem cell transplantation (ASCT), but for people who are too frail… read more here.
Keywords: senescence; age; ndmm; preliminary data ... See more keywords